Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy, Rolandic | 8 | 2023 | 54 | 5.720 |
Why?
|
Electroencephalography | 57 | 2024 | 6237 | 4.180 |
Why?
|
Epilepsy | 31 | 2024 | 3290 | 2.940 |
Why?
|
Seizures | 35 | 2024 | 2957 | 2.850 |
Why?
|
Thalamus | 6 | 2024 | 1047 | 1.910 |
Why?
|
Sleep Stages | 5 | 2024 | 694 | 1.760 |
Why?
|
Epilepsy, Generalized | 3 | 2024 | 178 | 1.590 |
Why?
|
Epilepsies, Partial | 4 | 2024 | 431 | 1.110 |
Why?
|
Cerebral Cortex | 11 | 2024 | 5779 | 1.010 |
Why?
|
Tuberous Sclerosis | 7 | 2020 | 1030 | 0.950 |
Why?
|
Action Potentials | 3 | 2024 | 1834 | 0.940 |
Why?
|
Sleep | 8 | 2024 | 4768 | 0.930 |
Why?
|
Scalp | 4 | 2021 | 389 | 0.920 |
Why?
|
Brain Waves | 4 | 2024 | 409 | 0.890 |
Why?
|
Nerve Net | 7 | 2021 | 2291 | 0.880 |
Why?
|
Models, Neurological | 6 | 2024 | 1769 | 0.870 |
Why?
|
Anticonvulsants | 14 | 2021 | 1906 | 0.850 |
Why?
|
Occipital Lobe | 2 | 2023 | 374 | 0.850 |
Why?
|
Brain Mapping | 9 | 2021 | 6635 | 0.840 |
Why?
|
Spasms, Infantile | 7 | 2022 | 298 | 0.820 |
Why?
|
Brain | 26 | 2024 | 27121 | 0.810 |
Why?
|
Angelman Syndrome | 2 | 2021 | 140 | 0.780 |
Why?
|
Delta Rhythm | 2 | 2021 | 81 | 0.760 |
Why?
|
Neural Pathways | 6 | 2022 | 3060 | 0.680 |
Why?
|
Cerebral Palsy | 1 | 2024 | 474 | 0.670 |
Why?
|
Infant, Newborn, Diseases | 6 | 2023 | 589 | 0.670 |
Why?
|
Child | 38 | 2024 | 80158 | 0.600 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1068 | 0.530 |
Why?
|
Malformations of Cortical Development | 1 | 2018 | 176 | 0.520 |
Why?
|
Gangliosidosis, GM1 | 1 | 2014 | 11 | 0.490 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1768 | 0.470 |
Why?
|
Pigmentation Disorders | 1 | 2014 | 105 | 0.450 |
Why?
|
Adolescent | 27 | 2024 | 88326 | 0.440 |
Why?
|
Muscle Hypotonia | 1 | 2014 | 161 | 0.430 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2023 | 352 | 0.420 |
Why?
|
Infant | 26 | 2024 | 36193 | 0.410 |
Why?
|
Child, Preschool | 27 | 2024 | 42232 | 0.410 |
Why?
|
Sp4 Transcription Factor | 1 | 2011 | 2 | 0.390 |
Why?
|
Humans | 99 | 2024 | 761596 | 0.390 |
Why?
|
Infant, Newborn | 25 | 2024 | 26202 | 0.380 |
Why?
|
Melanocytes | 1 | 2014 | 509 | 0.370 |
Why?
|
Sp1 Transcription Factor | 1 | 2011 | 140 | 0.360 |
Why?
|
Cognition | 3 | 2023 | 6992 | 0.350 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 244 | 0.330 |
Why?
|
Male | 61 | 2024 | 360846 | 0.320 |
Why?
|
Drugs, Investigational | 1 | 2010 | 212 | 0.310 |
Why?
|
Female | 60 | 2024 | 392705 | 0.310 |
Why?
|
Computer Simulation | 4 | 2016 | 6241 | 0.310 |
Why?
|
Consciousness | 3 | 2022 | 601 | 0.300 |
Why?
|
Parents | 4 | 2024 | 3563 | 0.290 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15266 | 0.290 |
Why?
|
Sensory Receptor Cells | 1 | 2011 | 513 | 0.270 |
Why?
|
Neurons | 2 | 2024 | 9463 | 0.250 |
Why?
|
Diffusion Tensor Imaging | 3 | 2023 | 2400 | 0.250 |
Why?
|
Young Adult | 16 | 2024 | 59260 | 0.230 |
Why?
|
Phenobarbital | 3 | 2021 | 191 | 0.220 |
Why?
|
Cysts | 1 | 2009 | 681 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36426 | 0.220 |
Why?
|
Electrooculography | 2 | 2013 | 113 | 0.210 |
Why?
|
Prospective Studies | 21 | 2024 | 54423 | 0.210 |
Why?
|
Stochastic Processes | 1 | 2024 | 355 | 0.210 |
Why?
|
Vigabatrin | 3 | 2022 | 88 | 0.210 |
Why?
|
Diazepam | 1 | 2023 | 215 | 0.200 |
Why?
|
Neurosurgical Procedures | 2 | 2024 | 2072 | 0.190 |
Why?
|
Status Epilepticus | 2 | 2020 | 460 | 0.190 |
Why?
|
Segmental Duplications, Genomic | 1 | 2021 | 19 | 0.190 |
Why?
|
Genomic Structural Variation | 1 | 2021 | 68 | 0.180 |
Why?
|
Caregivers | 3 | 2024 | 2238 | 0.180 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2021 | 65 | 0.180 |
Why?
|
Electrodes | 2 | 2021 | 614 | 0.180 |
Why?
|
Professional-Family Relations | 2 | 2021 | 495 | 0.170 |
Why?
|
Microelectrodes | 1 | 2021 | 306 | 0.170 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2021 | 350 | 0.170 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2020 | 1496 | 0.170 |
Why?
|
Anisotropy | 1 | 2023 | 1283 | 0.170 |
Why?
|
Algorithms | 3 | 2023 | 14033 | 0.170 |
Why?
|
Magnetoencephalography | 1 | 2023 | 636 | 0.160 |
Why?
|
Monitoring, Physiologic | 4 | 2024 | 1779 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2805 | 0.160 |
Why?
|
Williams Syndrome | 1 | 2021 | 194 | 0.160 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2016 | 53 | 0.150 |
Why?
|
Health Communication | 1 | 2021 | 213 | 0.150 |
Why?
|
Craniofacial Abnormalities | 1 | 2021 | 319 | 0.150 |
Why?
|
Critical Care | 3 | 2024 | 2697 | 0.150 |
Why?
|
Chromosome Disorders | 1 | 2021 | 497 | 0.150 |
Why?
|
Adult | 22 | 2024 | 221210 | 0.150 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2017 | 618 | 0.150 |
Why?
|
Somatosensory Cortex | 1 | 2000 | 512 | 0.140 |
Why?
|
Registries | 6 | 2024 | 8225 | 0.130 |
Why?
|
Child Health Services | 1 | 2022 | 646 | 0.130 |
Why?
|
Motor Cortex | 2 | 2000 | 1007 | 0.130 |
Why?
|
Electric Stimulation | 1 | 2021 | 1736 | 0.130 |
Why?
|
Language | 2 | 2023 | 1543 | 0.130 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2016 | 1473 | 0.130 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 2629 | 0.130 |
Why?
|
Wakefulness | 1 | 2022 | 1265 | 0.130 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 822 | 0.130 |
Why?
|
Family Health | 1 | 2020 | 1257 | 0.120 |
Why?
|
Hyperlipoproteinemia Type III | 1 | 2014 | 3 | 0.120 |
Why?
|
Neuronal Plasticity | 2 | 2000 | 1436 | 0.120 |
Why?
|
Evoked Potentials | 1 | 2021 | 1047 | 0.120 |
Why?
|
Alpha Rhythm | 1 | 2015 | 111 | 0.120 |
Why?
|
Persistent Vegetative State | 1 | 2017 | 273 | 0.120 |
Why?
|
Anesthetics | 1 | 2020 | 523 | 0.120 |
Why?
|
Infectious Disease Incubation Period | 1 | 2014 | 16 | 0.120 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2014 | 105 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2013 | 6228 | 0.110 |
Why?
|
Developmental Disabilities | 2 | 2021 | 1509 | 0.110 |
Why?
|
Rabies | 1 | 2014 | 54 | 0.110 |
Why?
|
Fourier Analysis | 1 | 2014 | 441 | 0.110 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11904 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1089 | 0.110 |
Why?
|
Middle Aged | 12 | 2024 | 220921 | 0.100 |
Why?
|
Disabled Persons | 1 | 2022 | 1226 | 0.100 |
Why?
|
Infant, Premature | 3 | 2017 | 2107 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1186 | 0.100 |
Why?
|
Lipase | 1 | 2014 | 325 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2242 | 0.100 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2928 | 0.100 |
Why?
|
Ectodermal Dysplasia | 1 | 2012 | 106 | 0.100 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 27 | 0.100 |
Why?
|
Fraser Syndrome | 1 | 2011 | 5 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1899 | 0.100 |
Why?
|
Hypertelorism | 1 | 2011 | 29 | 0.100 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2023 | 2791 | 0.090 |
Why?
|
PC12 Cells | 1 | 2011 | 317 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2014 | 992 | 0.090 |
Why?
|
Anus, Imperforate | 1 | 2011 | 63 | 0.090 |
Why?
|
Coloboma | 1 | 2011 | 59 | 0.090 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2012 | 412 | 0.090 |
Why?
|
Infant, Premature, Diseases | 1 | 2016 | 710 | 0.090 |
Why?
|
Nerve Growth Factor | 1 | 2011 | 158 | 0.090 |
Why?
|
Receptors, Interleukin | 1 | 2011 | 243 | 0.090 |
Why?
|
Risk Factors | 7 | 2021 | 74213 | 0.080 |
Why?
|
Cohort Studies | 11 | 2022 | 41495 | 0.080 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2010 | 134 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1443 | 0.080 |
Why?
|
Longevity | 2 | 2023 | 1065 | 0.080 |
Why?
|
Anxiety | 2 | 2020 | 4573 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39106 | 0.080 |
Why?
|
Ganglia, Spinal | 1 | 2011 | 526 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.070 |
Why?
|
Age of Onset | 4 | 2018 | 3306 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18399 | 0.070 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 543 | 0.070 |
Why?
|
Hamartoma | 1 | 2009 | 235 | 0.070 |
Why?
|
Motor Skills | 2 | 2000 | 521 | 0.070 |
Why?
|
Uncertainty | 2 | 2023 | 754 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1881 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2011 | 829 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1612 | 0.070 |
Why?
|
Animals | 9 | 2024 | 168475 | 0.070 |
Why?
|
Withholding Treatment | 2 | 2021 | 617 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4920 | 0.070 |
Why?
|
Phylogeny | 1 | 2014 | 2811 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2015 | 1220 | 0.060 |
Why?
|
Software | 1 | 2020 | 4434 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 80647 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2012 | 1987 | 0.060 |
Why?
|
Body Height | 1 | 2011 | 1570 | 0.060 |
Why?
|
Intralaminar Thalamic Nuclei | 1 | 2024 | 15 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4481 | 0.060 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2024 | 54 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14608 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3537 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4671 | 0.060 |
Why?
|
Premature Birth | 1 | 2016 | 1782 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5337 | 0.060 |
Why?
|
Forelimb | 2 | 2000 | 116 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1423 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2012 | 2571 | 0.050 |
Why?
|
Phase Transition | 1 | 2023 | 71 | 0.050 |
Why?
|
Rats, Long-Evans | 2 | 2000 | 383 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 210 | 0.050 |
Why?
|
Intensive Care, Neonatal | 1 | 2024 | 199 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2576 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3430 | 0.050 |
Why?
|
Frameshift Mutation | 2 | 2014 | 392 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 13367 | 0.050 |
Why?
|
Neonatology | 1 | 2024 | 140 | 0.050 |
Why?
|
Rats | 3 | 2011 | 23741 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1935 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8601 | 0.050 |
Why?
|
Chromosome Breakpoints | 1 | 2021 | 93 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3744 | 0.050 |
Why?
|
Rehabilitation | 1 | 2022 | 130 | 0.050 |
Why?
|
Implantable Neurostimulators | 1 | 2021 | 75 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4618 | 0.040 |
Why?
|
Depression | 1 | 2020 | 8126 | 0.040 |
Why?
|
Brain Diseases | 1 | 2009 | 1546 | 0.040 |
Why?
|
Neoplasms | 1 | 2009 | 22173 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 9001 | 0.040 |
Why?
|
United States | 8 | 2022 | 72340 | 0.040 |
Why?
|
Qualitative Research | 2 | 2021 | 3025 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5790 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2021 | 343 | 0.040 |
Why?
|
Nuclear Family | 1 | 2020 | 311 | 0.040 |
Why?
|
Virus Activation | 1 | 2021 | 322 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9353 | 0.040 |
Why?
|
Gestational Age | 2 | 2018 | 3577 | 0.040 |
Why?
|
Hindlimb | 1 | 2000 | 513 | 0.040 |
Why?
|
Models, Biological | 2 | 2012 | 9469 | 0.040 |
Why?
|
Dendrites | 1 | 2000 | 475 | 0.040 |
Why?
|
KCNQ3 Potassium Channel | 1 | 2017 | 10 | 0.040 |
Why?
|
Aged | 5 | 2021 | 169310 | 0.040 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2017 | 19 | 0.040 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3980 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23996 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2017 | 104 | 0.040 |
Why?
|
Object Attachment | 1 | 2020 | 326 | 0.040 |
Why?
|
Prednisolone | 1 | 2017 | 326 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 64685 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20100 | 0.030 |
Why?
|
Imagination | 1 | 2017 | 226 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1386 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2011 | 12794 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2021 | 753 | 0.030 |
Why?
|
Deep Brain Stimulation | 1 | 2024 | 832 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1440 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 580 | 0.030 |
Why?
|
Infant Mortality | 1 | 2020 | 759 | 0.030 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 753 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 846 | 0.030 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2014 | 6 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2018 | 22176 | 0.030 |
Why?
|
Xanthomatosis | 1 | 2014 | 32 | 0.030 |
Why?
|
Apolipoproteins C | 1 | 2014 | 59 | 0.030 |
Why?
|
Music | 1 | 2017 | 245 | 0.030 |
Why?
|
Patient Selection | 2 | 2021 | 4244 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6597 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 846 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2014 | 95 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 29890 | 0.030 |
Why?
|
Parenting | 1 | 2020 | 701 | 0.030 |
Why?
|
Synapses | 2 | 2000 | 1769 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2426 | 0.030 |
Why?
|
Functional Laterality | 1 | 2000 | 2257 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2606 | 0.030 |
Why?
|
Hospice Care | 1 | 2020 | 678 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1596 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7859 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2000 | 1878 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14665 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2000 | 1882 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13510 | 0.020 |
Why?
|
Brain Injuries | 2 | 2000 | 2054 | 0.020 |
Why?
|
Biophysics | 1 | 2012 | 380 | 0.020 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 74 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 642 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4740 | 0.020 |
Why?
|
Fear | 1 | 2020 | 1477 | 0.020 |
Why?
|
COS Cells | 1 | 2012 | 1130 | 0.020 |
Why?
|
Mutation | 3 | 2011 | 30053 | 0.020 |
Why?
|
Nose Diseases | 1 | 2011 | 79 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2011 | 503 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2012 | 784 | 0.020 |
Why?
|
Learning | 1 | 1999 | 1740 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 676 | 0.020 |
Why?
|
Hernia, Umbilical | 1 | 2011 | 102 | 0.020 |
Why?
|
Brazil | 1 | 2014 | 1230 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3683 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 15936 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7237 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3839 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.020 |
Why?
|
Eyelids | 1 | 2011 | 278 | 0.020 |
Why?
|
Finland | 1 | 2010 | 607 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1670 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15733 | 0.020 |
Why?
|
Anal Canal | 1 | 2011 | 373 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 877 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9647 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1860 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4021 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 7054 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12990 | 0.020 |
Why?
|
Nose | 1 | 2011 | 521 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6312 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2127 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2461 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1218 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 924 | 0.020 |
Why?
|
Anthropometry | 1 | 2011 | 1349 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1902 | 0.020 |
Why?
|
Signal Transduction | 1 | 2009 | 23447 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13255 | 0.020 |
Why?
|
Skin Diseases | 1 | 2014 | 1094 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58984 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16592 | 0.020 |
Why?
|
Syndrome | 1 | 2011 | 3267 | 0.010 |
Why?
|
Telemedicine | 1 | 2022 | 3052 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4111 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4576 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10554 | 0.010 |
Why?
|
Retina | 1 | 2014 | 2659 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39969 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4542 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3415 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2735 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3779 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6426 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1616 | 0.010 |
Why?
|
Critical Illness | 1 | 2014 | 2723 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5971 | 0.010 |
Why?
|
Mental Disorders | 1 | 2021 | 6845 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2457 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12441 | 0.010 |
Why?
|
Osteoporosis | 1 | 2009 | 1606 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4243 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6377 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17635 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6391 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15843 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4425 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17904 | 0.010 |
Why?
|
Mice | 2 | 2012 | 81539 | 0.010 |
Why?
|
Axons | 1 | 1999 | 1674 | 0.010 |
Why?
|
Motor Activity | 1 | 1999 | 2715 | 0.010 |
Why?
|